Common Contracts
2 similar Vaccine Adjuvant License and Collaboration Agreement contracts by Celldex Therapeutics Inc, Celldex Therapeutics, Inc.
Vaccine Adjuvant License and Collaboration AgreementVaccine Adjuvant License and Collaboration Agreement • March 5th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Minnesota
This Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).
Vaccine Adjuvant License and Collaboration AgreementVaccine Adjuvant License and Collaboration Agreement • March 2nd, 2009 • Celldex Therapeutics Inc • Biological products, (no disgnostic substances) • Minnesota
This Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).
